Cross Country Healthcare Q4 2025 revenue down 24% YoY; net loss of $82.9M

CROSS COUNTRY HEALTHCARE INC

Revenue $236.8M in Q4 2025, down 24% YoY; full-year revenue $1.054B, down 22%.
Net loss attributable to common $82.9M in Q4 versus $3.8M loss a year ago; diluted EPS $(2.56).
Adjusted EBITDA $4.1M in Q4, margin 1.7% (down 130bps YoY); full-year adjusted EBITDA $26.8M.
Cash from operations $18.2M in Q4; full year $48.3M, down 60% YoY.
Adjusted EPS was $(0.06) in Q4 vs $0.04 in prior-year quarter; full-year adjusted EPS $0.02.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CROSS COUNTRY HEALTHCARE INC reported fourth quarter and full year ended December 31, 2025 results: revenue $236,761, net income $(82,929), EPS $(2.56).

Period: fourth quarter and full year ended December 31, 2025
Revenue: $236,761
Net income: $(82,929)
EPS: $(2.56)
Result: reported results

Exact text from the filing

INFORMATION: Dollars are in thousands, except per share amounts Q4 2025 Variance Q4 2025 vs Q4 2024 Variance Q4 2025 vs Q3 2025 Full Year 2025 Variance 2025 vs 2024 Revenue $ 236,761 (24) % (5) % $ 1,054,293 (22) % Gross profit margin* 20.3 % 30 bps (10) bps 20.3 % (10) bps Net loss attributable to common stockholders $ (82,929) (2,110) % (1,637) % $ (94,852)

View on SEC.gov

Browse all earnings releases →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR

accession 0001628280-26-014650

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.